BELESALA Trademark

Trademark Overview


On Tuesday, September 10, 2019, a trademark application was filed for BELESALA with the United States Patent and Trademark Office. The USPTO has given the BELESALA trademark a serial number of 79273317. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by Mallinckrodt Pharmaceuticals Ireland Limited. The BELESALA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; syringes sold prefilled with pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, bili...

Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; medical device, namely, medical syringes used for manual injection
belesala

General Information


Serial Number79273317
Word MarkBELESALA
Filing DateTuesday, September 10, 2019
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6182097
Registration DateTuesday, October 27, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; syringes sold prefilled with pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders, and intravenous analgesics and antipyretics
Goods and ServicesMedical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; medical device, namely, medical syringes used for manual injection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressIE

Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type77 - NOT AVAILABLE
AddressIE

Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressIE

Trademark Events


Event DateEvent Description
Sunday, January 21, 2024NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 11, 2021GENERIC MADRID TRANSACTION SENT TO IB
Thursday, February 11, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, January 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Friday, August 7, 2020NOTIFICATION PROCESSED BY IB
Wednesday, July 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 22, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 7, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, July 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 7, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, July 7, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, July 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 8, 2020REFUSAL PROCESSED BY IB
Tuesday, January 21, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 21, 2020REFUSAL PROCESSED BY MPU
Thursday, December 12, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 11, 2019NON-FINAL ACTION WRITTEN
Wednesday, December 11, 2019ASSIGNED TO EXAMINER
Tuesday, December 10, 2019APPLICATION FILING RECEIPT MAILED
Friday, December 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB